患有多胞膜炎的儿科颗粒瘤:一个病例报告与过去10年的病例审查相比
Mariana Costin1, Eliza Cinteza2, Anca Croitoru1
1Pediatric Nephrology, Emergency Clinical Hospital for Children "Maria Sklodowska Curie", Bucharest, ROU.
Cureus
|February 10, 2025
概括
带有多叶膜炎 (GPA) 的粒状瘤炎是一种罕见的自身免疫性血管炎,影响儿童. 这种病例突出了早期发病的GPA与神经症状和MTHFR基因突变,强调了及时诊断和治疗.
科学领域:
- 儿科风湿病学 儿科风湿病学
- 自免疫性疾病 自免疫性疾病
- 血管炎是一种血管炎.
背景情况:
- 带有多叶膜炎 (GPA) 的粒状瘤,是一种罕见的自身免疫性血管炎,会影响中小血管.
- 虽然GPA在成年人中更常见,但也会影响儿童,由于其罕见性和复杂的症状,它会带来诊断挑战.
相关概念视频
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
967
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967
Pharmacokinetics in Pediatric Patients: Drug Metabolism
410
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410
Pharmacokinetics in Pediatric Patients: Drug Excretion
408
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408


